John K. Celebi
Net Worth
Last updated:
What is John K. Celebi net worth?
The estimated net worth of Mr. John K. Celebi is at least $1,944,617 as of 11 Sep 2023. He owns shares worth $879,357 as insider and has received compensation worth at least $1,065,260 in Sensei Biotherapeutics, Inc..
What is the salary of John K. Celebi?
Mr. John K. Celebi salary is $532,630 per year as Pres, Chief Executive Officer & Director in Sensei Biotherapeutics, Inc..
How old is John K. Celebi?
Mr. John K. Celebi is 53 years old, born in 1972.
What stocks does John K. Celebi currently own?
As insider, Mr. John K. Celebi owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Sensei Biotherapeutics, Inc. (SNSE) | Pres, Chief Executive Officer & Director | 111,311 | $7.9 | $879,357 |
What does Sensei Biotherapeutics, Inc. do?
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
John K. Celebi insider trading
Sensei Biotherapeutics key executives
Sensei Biotherapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Robert Hamilton Pierce M.D. (61) Chief Scientific Officer
- Mr. John K. Celebi (53) Pres, Chief Executive Officer & Director